FibroBiologics, Inc.

Pharmaceutical company · Houston, Texas, United States · Nasdaq: FBLG

FibroBiologics, Inc. is a pharmaceutical company headquartered in Houston, Texas, United States. Its earliest recorded incorporation is in 2021. Its shares trade on Nasdaq under the ticker FBLG. It has reported private securities offerings to the US SEC, most recently $3 million sold in a notice filed in 2026.

Profile compiled from public records. Is this your company? Request a correction or update

FibroBiologics at a glance

Typepharmaceutical company
HeadquartersHouston, Texas, United States
Earliest incorporation on record2021
Stock listingNasdaq: FBLG
SEC industryPharmaceutical Preparations
SEC CIK1958777

What does FibroBiologics do?

Private fundraising reported to the SEC

4 Form D notices; the most recent reported $3 million sold (2026).

Frequently asked questions about FibroBiologics

Where is FibroBiologics headquartered?

FibroBiologics, Inc. is headquartered in Houston, Texas, United States.

What does FibroBiologics do?

FibroBiologics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.

Is FibroBiologics a public company?

Yes. FibroBiologics, Inc. trades on Nasdaq under the ticker FBLG.

When was FibroBiologics founded?

The earliest incorporation on record for FibroBiologics, Inc. is in 2021, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences